Sapient Capital LLC Has $277,000 Stock Position in The Cigna Group (NYSE:CI)

Sapient Capital LLC lessened its position in shares of The Cigna Group (NYSE:CI) by 19.7% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 763 shares of the health services provider’s stock after selling 187 shares during the quarter. Sapient Capital LLC’s holdings in The Cigna Group were worth $277,000 at the end of the most recent quarter.

A number of other large investors also recently added to or reduced their stakes in CI. Bogart Wealth LLC grew its position in shares of The Cigna Group by 104.5% during the 3rd quarter. Bogart Wealth LLC now owns 90 shares of the health services provider’s stock worth $26,000 after buying an additional 46 shares during the period. OFI Invest Asset Management bought a new position in The Cigna Group during the third quarter worth about $26,000. Fortitude Family Office LLC bought a new stake in shares of The Cigna Group in the fourth quarter worth about $29,000. VisionPoint Advisory Group LLC lifted its position in shares of The Cigna Group by 112.2% in the third quarter. VisionPoint Advisory Group LLC now owns 104 shares of the health services provider’s stock worth $30,000 after purchasing an additional 55 shares in the last quarter. Finally, Raleigh Capital Management Inc. lifted its position in The Cigna Group by 69.5% during the 4th quarter. Raleigh Capital Management Inc. now owns 100 shares of the health services provider’s stock worth $30,000 after buying an additional 41 shares in the last quarter. 86.99% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on CI shares. Mizuho lifted their price objective on shares of The Cigna Group from $360.00 to $370.00 and gave the stock a “buy” rating in a research report on Monday, February 5th. Wells Fargo & Company raised their price target on shares of The Cigna Group from $334.00 to $348.00 and gave the stock an “equal weight” rating in a research report on Tuesday, February 6th. Barclays initiated coverage on The Cigna Group in a research note on Wednesday, March 6th. They issued an “overweight” rating and a $393.00 price target for the company. Royal Bank of Canada upgraded The Cigna Group from a “sector perform” rating to an “outperform” rating and raised their price objective for the stock from $327.00 to $354.00 in a research note on Monday, February 5th. Finally, Sanford C. Bernstein raised The Cigna Group from a “market perform” rating to an “outperform” rating and lifted their price objective for the company from $330.00 to $372.00 in a report on Thursday, January 4th. Two equities research analysts have rated the stock with a hold rating, ten have issued a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, The Cigna Group currently has an average rating of “Buy” and a consensus price target of $362.14.

The Cigna Group Price Performance

The Cigna Group stock traded up $0.67 during midday trading on Tuesday, reaching $357.11. The company’s stock had a trading volume of 1,216,208 shares, compared to its average volume of 1,561,397. The company has a current ratio of 0.67, a quick ratio of 0.67 and a debt-to-equity ratio of 0.61. The stock has a market cap of $104.40 billion, a PE ratio of 20.54, a price-to-earnings-growth ratio of 1.09 and a beta of 0.56. The Cigna Group has a 52 week low of $240.50 and a 52 week high of $365.71. The business has a 50-day moving average price of $350.50 and a 200-day moving average price of $318.94.

The Cigna Group (NYSE:CI) last announced its quarterly earnings results on Friday, February 2nd. The health services provider reported $6.79 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.54 by $0.25. The Cigna Group had a net margin of 2.64% and a return on equity of 13.59%. The company had revenue of $51.15 billion for the quarter, compared to analyst estimates of $48.91 billion. During the same period in the previous year, the firm posted $4.96 EPS. The firm’s revenue was up 11.8% on a year-over-year basis. On average, sell-side analysts predict that The Cigna Group will post 28.36 EPS for the current year.

The Cigna Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, June 20th. Investors of record on Tuesday, June 4th will be given a dividend of $1.40 per share. The ex-dividend date of this dividend is Tuesday, June 4th. This represents a $5.60 dividend on an annualized basis and a yield of 1.57%. The Cigna Group’s dividend payout ratio is currently 32.20%.

Insiders Place Their Bets

In other news, SVP Hoeltzel Mary T. Agoglia sold 4,867 shares of The Cigna Group stock in a transaction dated Wednesday, February 7th. The stock was sold at an average price of $330.48, for a total transaction of $1,608,446.16. Following the sale, the senior vice president now directly owns 2,102 shares of the company’s stock, valued at $694,668.96. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, CEO David Cordani sold 31,209 shares of the firm’s stock in a transaction on Monday, March 25th. The stock was sold at an average price of $355.17, for a total transaction of $11,084,500.53. Following the completion of the transaction, the chief executive officer now directly owns 348,054 shares of the company’s stock, valued at approximately $123,618,339.18. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, SVP Hoeltzel Mary T. Agoglia sold 4,867 shares of the company’s stock in a transaction dated Wednesday, February 7th. The shares were sold at an average price of $330.48, for a total value of $1,608,446.16. Following the completion of the sale, the senior vice president now owns 2,102 shares in the company, valued at approximately $694,668.96. The disclosure for this sale can be found here. Insiders sold a total of 114,144 shares of company stock valued at $39,296,330 in the last 90 days. Corporate insiders own 0.70% of the company’s stock.

About The Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.